While discussing ways to strengthen India's pharmaceutical industry post COVID-19, Mr. Rajaram Narayanan, MD, @Sanofi (India) shared his thoughts on how to boost India's #pharma ecosystem by leveraging its strength in #manufacturing and R&D.
#pharmaceutical@mansukhmandviya
#Diabetes is a growing epidemic in India. We initiated a real world LANDMARC study to gain insights on its complications on Indian patients. Learn more from this @livemint article.